EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

BCAT1 Activation Reprograms Branched-Chain Amino Acid Metabolism and Epigenetically Promotes Inflammation in Diabetic Retinopathy

Jingyi Wang, Zihan Yin, Jingxiao Yang, Sijun Sun, Xiaofang Tang, Shengjie Zhang, Yi-Ping Wang, Haiyan Wang

Investigative Ophthalmology & Visual Science · 2025-06-18 · 66 (6) · 59

DOI: 10.1167/iovs.66.6.59 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, published on 2025-06-18. Written by Jingyi Wang and 7 co-authors. Institution: Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye D…. Major MEDLINE topics: Diabetic Retinopathy, Amino Acids, Branched-Chain, Epigenesis, Genetic, Transaminases. Cited 12 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

To investigate how branched-chain amino acid (BCAA) metabolism is remodeled and to determine its contribution to diabetic retinopathy progression.

Methods

We analyzed Bcat1 and Bcat2 expression in the retina using single-cell sequencing data and immunofluorescence. Bcat1-mediated remodeling of BCAA metabolism was assessed via targeted metabolomics in Müller cells. We performed chromatin immunoprecipitation (ChIP) to examine histone methylation at inflammatory gene promoters. Additionally, we utilized RNA sequencing and kinase screening assays to delineate phosphorylation regulation of Bcat1 activity. In vivo, we established diabetic mouse models and treated them with Bcat1-specific inhibitor to evaluate retinal inflammation and vascular leakage.

Results

Bcat1 was predominantly expressed in Müller cells and exhibited increased activity under diabetic conditions, leading to a remodeling of BCAA catabolism and upregulation of inflammatory genes (interleukin 6 [Il6] and tumor necrosis factor-α [Tnf-α]). Bcat1 activity was negatively regulated by polo-like kinase 4 (Plk4)-mediated phosphorylation at threonine 333. In high glucose-treated Müller cells, elevated Bcat1 activity reduced α-ketoglutarate (α-KG), a critical substrate for histone demethylation reactions, resulting in higher histone H3 lysine 4 trimethylation (H3K4me3) levels at inflammatory gene promoters, and further boosted retinal inflammation. Treatment with chemical Bcat1 inhibitors (BAY-069 and ERG240) significantly reduced inflammatory gene expression and vascular leakage in diabetic retinas in vivo.

Conclusions

Bcat1 activation mediates BCAA metabolism remodeling in Müller cells and epigenetically induces retinal inflammation, which offers a potential therapeutic target for diabetic retinopathy. Diabetes and diabetic retinopathy are potentially driven not only by hyperglycemia but also by dysregulated amino acid metabolism.

Subjects

MeSH terms (MEDLINE)

Diabetic RetinopathyAmino Acids, Branched-ChainEpigenesis, GeneticTransaminasesGene Expression RegulationAnimalsMiceMice, Inbred C57BLDiabetes Mellitus, ExperimentalEpendymoglial CellsInflammationMaleChromatin ImmunoprecipitationPhosphorylation

Substances

Amino Acids, Branched-ChainTransaminases

Authors and institutions

  • Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai Clinical Research Center for Eye Diseases, Shanghai…
  • Precision Research Center for Refractory Diseases, Shanghai Jiao Tong University Pioneer Research Institute for Molecular and Cell Therapies, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine,…
  • State Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, China.

Cite

APA

Wang, J., Yin, Z., Yang, J., Sun, S., Tang, X., Zhang, S., Wang, Y. P., & Wang, H. (2025). BCAT1 Activation Reprograms Branched-Chain Amino Acid Metabolism and Epigenetically Promotes Inflammation in Diabetic Retinopathy. Investigative Ophthalmology & Visual Science, 66(6), 59. https://doi.org/10.1167/iovs.66.6.59

Vancouver

Wang J, Yin Z, Yang J, Sun S, Tang X, Zhang S, et al. BCAT1 Activation Reprograms Branched-Chain Amino Acid Metabolism and Epigenetically Promotes Inflammation in Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 2025;66(6):59. doi:10.1167/iovs.66.6.59

BibTeX
@article{Wang2025,
  author = {Wang, Jingyi and Yin, Zihan and Yang, Jingxiao and Sun, Sijun and Tang, Xiaofang and Zhang, Shengjie and Wang, Yi-Ping and Wang, Haiyan},
  title = {BCAT1 Activation Reprograms Branched-Chain Amino Acid Metabolism and Epigenetically Promotes Inflammation in Diabetic Retinopathy},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  volume = {66},
  number = {6},
  pages = {59},
  doi = {10.1167/iovs.66.6.59}
}
Start for free →